Skip to content

CLAEYSPHARMA

Active Risk: not assessed
Private limited companyfounded 2009active for 16 yearsBredestraat Kouter 69, 9920 Lievegem, BelgiumKBO/BCE: BE 0820.858.045
Summary

CLAEYSPHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.8m and a net result of €142,030. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 69% of 6,658 sector peers (NACE 64, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals.

History

On 24 November 2009, CLAEYSPHARMA was incorporated.1 CLAEYS Katrien Emiel Anna Maurice has served as director of the company since 2023.2 Total assets went from €1.6m in 2018 to €2.5m in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 10-01-2024
  3. 3National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
28-08
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 28 days late
2025
29-08
NBB filing Annual accounts filed
financial year 2024 · abbreviated format · 29 days late
2024
15-07
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
10-01
Gazette deed Reappointment: CLAEYS Katrien Emiel Anna Maurice (director)
Amendment of the articles · Legal form clause · Capital conversion12 facts ▸
  • General meeting, “buitengewone algemene vergadering, eenparigheid van stemmen” (deed in Dutch)
  • Amendment of the articles (2 times)
  • Legal form clause, “behouden, besloten vennootschap” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Capital conversion, “eigen vermogensrekening "niet-opgevraagde inbrengen"” (deed in Dutch)
  • Reserve release, “statutair onbeschikbare eigen vermogensrekening opheffen, middelen beschikbaar voor uitkering” (deed in Dutch)
  • Amendment of the articles, 18
  • Capital
  • Director reappointment, CLAEYS Katrien Emiel Anna Maurice (director)
  • Registered office clause, “9920 Lievegem (Lovendegem), Bredestraat Kouter 69” (deed in Dutch)
  • Other provision, “coördinatie van de statuten op te maken en te ondertekenen, in overeenstemming met de vorige besluiten, en de neerlegging daarvan in het vennootschapsdossier te…” (deed in Dutch)
  • Power of attorney
2023
31-08
NBB filing Annual accounts filed
financial year 2022 · abbreviated format · 31 days late
2022
31-12
Financial Highest result from 2018 to 2025net €199,085 ▲48.8%
Net result €199,085, the highest in the series.
31-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 31 days late
2021
31-12
Financial Equity above €1mequity €1.1m ▲13.8%
A profit in every financial year since 2018 builds equity to €1.1m.
29-09
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 60 days late
2020
06-11
NBB filing Annual accounts filed
financial year 2019 · abbreviated format · 98 days late
2019
14-08
NBB filing Annual accounts filed
financial year 2018 · abbreviated format · 14 days late
2018
30-08
NBB filing Annual accounts filed
financial year 2017 · abbreviated format · 30 days late
2017
30-08
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 30 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all 16 are under Financials.
1 of 1 deed read